Effects of coenzyme Q10 supplementation on lipid profiles and liver enzymes of nonalcoholic fatty liver disease (NAFLD) patients: A systematic review and meta‐analysis of randomized controlled trials

As an antioxidant, coenzyme Q 10 (CoQ10) has been proposed as a possible treatment for non‐alcoholic fatty liver disease (NAFLD). In the present meta‐analysis, we aimed to determine the effects of CoQ10 supplementation on lipid profiles and liver enzymes of NAFLD patients. We searched PubMed, Web of...

Descripción completa

Detalles Bibliográficos
Autores principales: Ardekani, Ali, Tabrizi, Reza, Maleki, Elham, Bagheri Lankarani, Kamran, Heydari, Seyed Taghi, Moradinazar, Mehdi, Akbari, Maryam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10261764/
https://www.ncbi.nlm.nih.gov/pubmed/37324909
http://dx.doi.org/10.1002/fsn3.3315

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10261764/
https://www.ncbi.nlm.nih.gov/pubmed/37324909
http://dx.doi.org/10.1002/fsn3.3315

Ejemplares similares